Skip to main content
    P

    Pennant Group Inc (PNTG)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $40.82
    +0.67 (+1.67%)

    Market Cap: $1.43B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    72%(21/29)
    Avg Surprise
    +1.84%
    Streak
    13 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.35
    Range$0.33 - $0.37
    7 analysts
    EPS Revisions
    1
    0
    7d
    5
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$0.34+3.3%
    60d ago$0.35+1.6%
    30d ago$0.350.0%
    7d ago$0.350.0%
    Current$0.35
    Revenue Consensus
    $299M
    Range$297M - $303M
    6 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.41
    Range$0.39 - $0.43
    7 analysts
    Revenue Consensus
    $314M
    Range$311M - $318M
    7 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.41---
    Sep 26EST
    		-$0.35---
    Jun 26
    Reported Aug 5
    		$0.29$0.28+3.57%Beat+7.4%
    Mar 26
    Reported May 6
    		$0.32$0.31+3.23%Beat+18.5%
    Dec 25
    Reported Feb 25
    		$0.34$0.32+7.70%Beat+41.7%
    Sep 25
    Reported Nov 5
    		$0.25$0.24+4.17%Beat-3.8%
    Jun 25
    Reported Aug 6
    		$0.27$0.27+0.00%Beat+12.5%
    Mar 25
    Reported May 6
    		$0.27$0.24+12.50%Beat+35.0%
    Dec 24
    Reported Feb 27
    		$0.24$0.24+0.00%Beat+9.1%
    Sep 24
    Reported Nov 6
    		$0.26$0.23+13.04%Beat+30.0%
    Jun 24
    Reported Aug 6
    		$0.24$0.22+9.09%Beat+33.3%
    Mar 24
    Reported May 6
    		$0.20$0.17+17.65%Beat+53.8%
    Dec 23
    Reported Feb 28
    		$0.22$0.22+0.00%Beat+22.2%
    Sep 23
    Reported Nov 7
    		$0.20$0.19+5.26%Beat+42.9%
    Jun 23
    Reported Aug 8
    		$0.18$0.16+12.50%Beat+28.6%
    Mar 23
    Reported May 4
    		$0.13$0.14-7.14%Miss+30.0%
    Dec 22
    Reported Feb 23
    		$0.18$0.18+0.00%Beat+157.1%
    Sep 22
    Reported Nov 7
    		$0.14$0.18-22.22%Miss+27.3%
    Jun 22
    Reported Aug 8
    		$0.14$0.14+0.00%Beat-17.6%
    Mar 22
    Reported May 9
    		$0.10$0.08+25.00%Beat-9.1%
    Dec 21
    Reported Feb 28
    		$0.07N/A-53.33%Miss-58.8%
    Sep 21
    Reported Nov 8
    		$0.11$0.18-38.89%Miss-38.9%
    Jun 21
    Reported Aug 9
    		$0.17$0.21-19.05%Miss-29.2%
    Mar 21
    Reported May 6
    		$0.11$0.19-42.11%Miss-31.3%
    Dec 20
    Reported Feb 24
    		$0.17$0.20-15.00%Miss+6.3%
    Sep 20
    Reported Nov 10
    		$0.18$0.17+5.88%Beat+12.5%
    Jun 20
    Reported Aug 11
    		$0.24$0.12+100.00%Beat+166.7%
    Mar 20
    Reported May 13
    		$0.16$0.13+23.08%Beat-
    Dec 19
    Reported Mar 4
    		$0.16$0.16+0.00%Beat-
    Sep 19
    Reported Oct 1
    		$0.16$0.12+33.33%Beat-
    Jun 19
    Reported Aug 28
    		$0.09$0.12-25.00%Miss-

    Key Metrics

    Valuation
    P/E Ratio34.02EV/EBITDA21.65x
    Price/FCF41.00xFCF Yield2.44%
    Profitability
    Profit Margin2.93%Operating Margin6.19%
    ROE10.40%ROIC8.26%
    Financial Health
    Debt/Equity0.55xInterest Coverage5.89x
    Current Ratio1.20xQuick Ratio1.20x
    Trading Statistics
    Beta1.25Avg Volume417.85K
    52-Week High$42.7452-Week Low$22.25

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$39.95
    SMA 20$39.90
    SMA 50$39.28
    SMA 200$34.65
    EMA 10$40.15
    EMA 20$39.93
    EMA 50$39.34
    EMA 200$35.28

    MACD

    Line: 0.28Signal: 0.23Hist: 0.05

    ADX

    ADX: 17.9+DI: 18.9-DI: 14.0

    Aroon & PSAR

    Aroon Up24.0
    Aroon Down64.0
    PSAR$40.99

    Bollinger Bands

    Upper Band$41.17
    Lower Band$38.62
    %B Position640%(Upper)
    Band Width0.86

    RSI (14-Day)

    Neutral
    56.3

    Momentum Oscillators

    Stoch %K69.1
    Stoch %D62.9
    Williams %R-21.8
    ROC (10d)4.7%
    Momentum1.82
    CCI (20d)87.3
    MFI (14d)60.4

    Volatility Measures

    ATR (14d)$1.35(3.3%)
    StdDev (20d)0.64
    Hist Vol33.6%(Moderate)

    Volume Flow

    VWAP$40.60
    OBV9.2M
    AD Line3.3M
    CMF (20d)-0.159

    Volume Metrics

    Avg Vol (20d)390.8K
    Vol Ratio0.4x(Low)
    VWMA (20d)$39.89

    Pivot Points

    R3$41.85
    R2$41.38
    R1$40.77
    Pivot Point$40.30
    S1$39.69
    S2$39.22
    S3$38.61

    Advanced Oscillators

    TSI6.27
    Ultimate Osc47.4
    KST21.41

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$297.98M$285.36M$289.32M$229.04M$219.50M$209.84M$188.89M$180.69M$168.75M$156.91M$145.95M$140.19M
    Cost of Revenue$242.63M$232.66M$237.05M$185.43M$177.28M$168.75M$152.67M$144.47M$135.31M$126.00M$116.93M$112.38M
    Gross Profit$55.35M$52.70M$52.27M$43.61M$42.23M$41.10M$36.22M$36.22M$33.43M$30.92M$29.02M$27.81M
    Operating Expenses$38.16M$35.40M$34.80M$33.37M$30.70M$28.45M$26.98M$25.43M$23.87M$22.40M$21.45M$20.75M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$21.61M$19.69M$19.34M$19.30M$17.60M$14.84M$13.87M$13.02M$11.88M$11.44M$9.75M$9.42M
    Operating Income$17.19M$17.30M$17.47M$10.24M$11.53M$12.65M$9.24M$10.79M$9.56M$8.52M$7.57M$7.06M
    Interest Income$370,000$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$3.35M$3.07M$3.25M$1.02M$1.20M$1.21M$650,000$2.89M$1.62M$1.79M$1.57M$1.50M
    Income Before Tax$14.83M$14.09M$14.27M$9.40M$10.58M$11.38M$8.60M$8.01M$7.94M$6.82M$6.31M$5.53M
    Income Tax Expense$3.94M$3.79M$3.90M$2.52M$2.60M$2.85M$2.07M$1.35M$1.84M$1.76M$1.78M$1.07M
    Net Income$10.90M$10.29M$10.38M$6.89M$7.98M$8.52M$6.53M$6.66M$6.09M$5.06M$4.53M$4.46M
    EBITDA$21.22M$20.08M$20.12M$12.70M$14.22M$14.69M$11.30M$13.01M$11.16M$10.07M$9.32M$8.48M
    EBIT$17.81M$17.16M$17.52M$10.42M$11.78M$12.58M$9.25M$10.90M$9.56M$8.61M$7.88M$7.02M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PNTG

    News

    Pennant Group stock has November 4 earnings date and USD 299.34 million estimate

    The Pennant Group (PNTG) is scheduled to release its next earnings report on November 4, 2026, with analysts estimating revenue of USD 299.34 million and earnings per share of USD 0.36. The company's market...

    ad-hoc-news.de•10/15/26•Somewhat-Bullish

    Pennant Group stock has November 4 earnings date and USD 299.34 million estimate

    The Pennant Group (PNTG) is scheduled to release its next earnings report on November 4, 2026, with analysts estimating revenues of USD 299.34 million and earnings of USD 0.36 per share for the third quarter....

    ad-hoc-news.de•10/15/26•Somewhat-Bullish

    How The Pennant Group Inc. (PNTG) Affects Rotational Strategy Timing

    The Pennant Group Inc. (PNTG) shows neutral near and mid-term readings, potentially moderating its long-term positive bias, with an oscillation pattern in play. Exceptional risk-reward for a short setup is identified...

    Stock Traders Daily•10/13/26•Neutral

    Pennant Group plans Oppenheimer meeting. RBC targets Pennant Group stock at USD 44.00

    Pennant Group (PNTG) will meet with Oppenheimer on October 13, 2026, while RBC has raised its price target for the stock from USD 42.00 to USD 44.00. The company reported strong second-quarter results...

    AD HOC NEWS•10/8/26•Bullish

    Pennant Group plans Oppenheimer meeting. RBC targets Pennant Group stock at USD 44.00

    The Pennant Group (PNTG) will meet with Oppenheimer in Boston on October 13, 2026, following RBC raising its target price for the stock from USD 42.00 to USD 44.00. The company reported strong Q2 2026 results...

    AD HOC NEWS•10/8/26•Somewhat-Bullish

    PNTG Valuation and Fair Value

    P/E
    34.0x
    Forward P/E
    25.4x
    EV/EBITDA
    21.6x
    P/FCF
    41.0x
    PEG
    2.0x
    P/B
    4.0x
    See GNG's fair value

    PNTG Profitability: Margins, ROIC and FCF

    Gross margin
    18.5%
    Operating margin
    6.2%
    Net margin
    2.9%
    ROIC
    8.3%
    ROE
    10.4%
    FCF margin
    3.1%
    FCF yield
    2.4%

    PNTG Competitors

    CompanyTicker
    Healthcare Services Group IncHCSG
    AMN Healthcare Services IncAMN
    Pacira BioSciences, Inc.PCRX
    Nutex Health IncNUTX
    Uniqure NVQURE
    Kalvista Pharmaceuticals IncKALV
    Immunocore Holdings LtdIMCR
    Rapport Therapeutics, Inc. Common StockRAPP

    Sector: Healthcare

    PNTG Analyst Ratings

    Consensus
    Buy
    Analysts
    7
    Strong Buy
    1
    Buy
    6
    Hold
    0
    Sell
    0
    Strong Sell
    0

    PNTG Bull Case vs Bear Case

    Bull case

    • PNTG beat EPS estimates in 75.0% of its last 8 reported quarters.
    • PNTG grew quarterly revenue 35.8% year over year.
    • 100.0% of PNTG's analyst ratings are Buy or Strong Buy.

    PNTG Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    5.5%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.35
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    5 up, 0 down

    Frequently Asked Questions About PNTG

    Does PNTG pay dividends?

    Pennant Group Inc (PNTG) does not currently pay a regular dividend.

    What is PNTG's P/E ratio?

    Pennant Group Inc has a price-to-earnings (P/E) ratio of 34.02.

    What is PNTG's market cap?

    Pennant Group Inc (PNTG) has a market capitalization of $1.43B with a current stock price of $40.82.

    Related stocks

    Sector: Healthcare

    All stocks starting with P

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In